Switch to:
PDL BioPharma Inc (NAS:PDLI)
EV/EBITDA
2.63 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, PDL BioPharma Inc's enterprise value is $1,471.1 Mil. PDL BioPharma Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $562.0 Mil. Therefore, PDL BioPharma Inc's EV/EBITDA ratio for today is 2.63.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, PDL BioPharma Inc's stock price is $7.84. PDL BioPharma Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $1.93. Therefore, PDL BioPharma Inc's P/E Ratio for today is 4.10.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

PDL BioPharma Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=1471.147/561.98
=2.62

PDL BioPharma Inc's current Enterprise Value is $1,471.1 Mil.
PDL BioPharma Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was 109.018 (Dec. 2013 ) + 138.015 (Mar. 2014 ) + 155.914 (Jun. 2014 ) + 159.033 (Sep. 2014 ) = $562.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

PDL BioPharma Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.84/1.927
=4.07

PDL BioPharma Inc's share price for today is $7.84.
PDL BioPharma Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was 0.357 (Dec. 2013 ) + 0.44 (Mar. 2014 ) + 0.52 (Jun. 2014 ) + 0.61 (Sep. 2014 ) = $1.93.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda -38.45-24.88-47.6323.823.914.145.863.093.213.42

PDL BioPharma Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda 3.013.573.213.062.872.723.423.153.712.54
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK